- Home
- IREN vs MRUS Comparison
IREN vs MRUS Comparison
Compare IREN & MRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IREN
- MRUS
- Stock Information
- Founded
- IREN 2018
- MRUS 2003
- Country
- IREN Australia
- MRUS Netherlands
- Employees
- IREN N/A
- MRUS N/A
- Industry
- IREN EDP Services
- MRUS Biotechnology: Pharmaceutical Preparations
- Sector
- IREN Technology
- MRUS Health Care
- Exchange
- IREN Nasdaq
- MRUS Nasdaq
- Market Cap
- IREN 4.4B
- MRUS 4.1B
- IPO Year
- IREN 2021
- MRUS 2016
- Fundamental
- Price
- IREN $19.35
- MRUS $67.00
- Analyst Decision
- IREN Strong Buy
- MRUS Strong Buy
- Analyst Count
- IREN 10
- MRUS 12
- Target Price
- IREN $19.67
- MRUS $91.00
- AVG Volume (30 Days)
- IREN 25.4M
- MRUS 661.7K
- Earning Date
- IREN 08-28-2025
- MRUS 08-05-2025
- Dividend Yield
- IREN N/A
- MRUS N/A
- EPS Growth
- IREN N/A
- MRUS N/A
- EPS
- IREN N/A
- MRUS N/A
- Revenue
- IREN $377,821,000.00
- MRUS $56,228,000.00
- Revenue This Year
- IREN $169.71
- MRUS $67.27
- Revenue Next Year
- IREN $84.23
- MRUS $0.49
- P/E Ratio
- IREN N/A
- MRUS N/A
- Revenue Growth
- IREN 128.24
- MRUS 59.77
- 52 Week Low
- IREN $5.13
- MRUS $33.19
- 52 Week High
- IREN $21.54
- MRUS $67.59
- Technical
- Relative Strength Index (RSI)
- IREN 59.26
- MRUS 64.93
- Support Level
- IREN $17.56
- MRUS $63.21
- Resistance Level
- IREN $19.38
- MRUS $67.59
- Average True Range (ATR)
- IREN 1.16
- MRUS 2.22
- MACD
- IREN -0.04
- MRUS -0.27
- Stochastic Oscillator
- IREN 70.12
- MRUS 97.33
About IREN Iris Energy Limited
IREN Ltd is engaged in data center business powering the future of Bitcoin, AI and beyond utilizing renewable energy.
About MRUS Merus N.V.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.